This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HCAQ vs. BMEA, SKYE, ANIX, TARA, CGTX, SEER, IKT, LUCD, SERA, and WGRXShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Biomea Fusion (BMEA), Skye Bioscience (SKYE), Anixa Biosciences (ANIX), Protara Therapeutics (TARA), Cognition Therapeutics (CGTX), Seer (SEER), Inhibikase Therapeutics (IKT), Lucid Diagnostics (LUCD), Sera Prognostics (SERA), and Wellgistics Health (WGRX). These companies are all part of the "medical" sector. HealthCor Catalio Acquisition vs. Its Competitors Biomea Fusion Skye Bioscience Anixa Biosciences Protara Therapeutics Cognition Therapeutics Seer Inhibikase Therapeutics Lucid Diagnostics Sera Prognostics Wellgistics Health Biomea Fusion (NASDAQ:BMEA) and HealthCor Catalio Acquisition (NASDAQ:HCAQ) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Do institutionals and insiders have more ownership in BMEA or HCAQ? 96.7% of Biomea Fusion shares are owned by institutional investors. Comparatively, 84.2% of HealthCor Catalio Acquisition shares are owned by institutional investors. 18.4% of Biomea Fusion shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is BMEA or HCAQ more profitable? HealthCor Catalio Acquisition's return on equity of 0.00% beat Biomea Fusion's return on equity.Company Net Margins Return on Equity Return on Assets Biomea FusionN/A -243.95% -140.74% HealthCor Catalio Acquisition N/A N/A N/A Do analysts recommend BMEA or HCAQ? Biomea Fusion currently has a consensus price target of $14.80, suggesting a potential upside of 629.06%. Given Biomea Fusion's stronger consensus rating and higher possible upside, equities research analysts plainly believe Biomea Fusion is more favorable than HealthCor Catalio Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomea Fusion 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 3 Strong Buy rating(s) 3.17HealthCor Catalio Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings and valuation, BMEA or HCAQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiomea FusionN/AN/A-$138.43M-$3.03-0.67HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A Does the media prefer BMEA or HCAQ? In the previous week, Biomea Fusion had 4 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 4 mentions for Biomea Fusion and 0 mentions for HealthCor Catalio Acquisition. Biomea Fusion's average media sentiment score of 0.22 beat HealthCor Catalio Acquisition's score of 0.00 indicating that Biomea Fusion is being referred to more favorably in the media. Company Overall Sentiment Biomea Fusion Neutral HealthCor Catalio Acquisition Neutral SummaryBiomea Fusion beats HealthCor Catalio Acquisition on 8 of the 10 factors compared between the two stocks. Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.76M$11.41B$5.79B$10.46BDividend YieldN/A1.84%5.61%4.57%P/E RatioN/A18.33348.7126.86Price / SalesN/A7.60554.60125.65Price / CashN/A11.9026.0131.15Price / BookN/A2.0215.876.50Net IncomeN/A$344.53M$3.29B$271.25M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$1.49+2.8%N/A+38.1%$31.76MN/A0.002High Trading VolumeBMEABiomea Fusion3.2993 of 5 stars$1.96-3.0%$14.80+655.1%-76.5%$120.21MN/A-0.6550SKYESkye Bioscience1.7176 of 5 stars$3.91+1.3%$15.50+296.4%+23.9%$119.61MN/A-3.6911ANIXAnixa Biosciences3.1193 of 5 stars$3.35-6.9%$9.00+168.7%+0.3%$118.50M$210K-9.575News CoverageAnalyst ForecastGap UpHigh Trading VolumeTARAProtara Therapeutics1.4944 of 5 stars$3.03-1.3%$19.60+546.9%+85.4%$118.45MN/A-1.8730Gap UpCGTXCognition Therapeutics3.044 of 5 stars$1.47-8.7%$2.83+92.7%+146.7%$118.37MN/A-2.1920Positive NewsSEERSeer0.7302 of 5 stars$2.06-1.4%N/A+28.5%$117.75M$14.17M-1.48160IKTInhibikase Therapeutics1.2783 of 5 stars$1.56flat$6.50+316.7%+40.0%$116.25MN/A-0.586LUCDLucid Diagnostics2.7843 of 5 stars$1.07flat$3.65+241.1%+30.9%$116.07M$4.35M-0.9070Analyst DowngradeSERASera Prognostics1.3227 of 5 stars$3.21+4.2%N/A-55.7%$116.03M$80K-3.78120WGRXWellgistics HealthN/A$1.40+2.2%N/AN/A$115.17M$18.13M0.0031Gap Down Related Companies and Tools Related Companies BMEA Competitors SKYE Competitors ANIX Competitors TARA Competitors CGTX Competitors SEER Competitors IKT Competitors LUCD Competitors SERA Competitors WGRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCAQ) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCAQ Stock Alerts